Kotańska, M., Śniecikowska, J., Jastrzębska-Więsek, M., Kołaczkowski, M., & Pytka, K. (2017). Metabolic and Cardiovascular Benefits and Risks of EMD386088—A 5-HT(6) Receptor Partial Agonist and Dopamine Transporter Inhibitor. Front Neurosci.
استشهاد بنمط شيكاغوKotańska, Magdalena, Joanna Śniecikowska, Magdalena Jastrzębska-Więsek, Marcin Kołaczkowski, و Karolina Pytka. "Metabolic and Cardiovascular Benefits and Risks of EMD386088—A 5-HT(6) Receptor Partial Agonist and Dopamine Transporter Inhibitor." Front Neurosci 2017.
MLA استشهادKotańska, Magdalena, et al. "Metabolic and Cardiovascular Benefits and Risks of EMD386088—A 5-HT(6) Receptor Partial Agonist and Dopamine Transporter Inhibitor." Front Neurosci 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.